Joel Greenblatt Ultragenyx Pharmaceutical Inc.

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$38.8

Avg closing price
Price range
Joel Greenblatt Portfolio Stock Details (RARE)

11 Joel Greenblatt Ultragenyx Pharmaceutical Trades

The first Ultragenyx Pharmaceutical trade was made in Q1 2019. Since then Joel Greenblatt bought shares five more times and sold shares on five occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Ultragenyx Pharmaceutical anymore.

Avg closing price
Price range
Sold -7.48 Thousand shares Q2 2024
Avg closing price $42.70
Price range $37.42 - $51.61
New holding (+7.48 Thousand shares) Q4 2023
Avg closing price $38.77
Price range $31.73 - $49.19
Sold -15.8 Thousand shares Q3 2023
Avg closing price $39.62
Price range $34.92 - $46.66
Sold 16.1% shares (-3.04 Thousand shares) Q2 2023
Avg closing price $46.38
Price range $37.35 - $52.15
Increased shares by 107.7% (+9.78 Thousand shares) Q1 2023
Avg closing price $42.91
Price range $36.99 - $48.71
Increased shares by 53.8% (+3.18 Thousand shares) Q4 2022
Avg closing price $39.33
Price range $33.72 - $46.33
New holding (+5.91 Thousand shares) Q3 2022
Avg closing price $51.39
Price range $39.96 - $66.14
Sold -1.55 Thousand shares Q1 2021
Avg closing price $136.14
Price range $106.90 - $167.73
New holding (+1.55 Thousand shares) Q4 2020
Avg closing price $118.63
Price range $84.40 - $177.39
Sold -4.56 Thousand shares Q2 2019
Avg closing price $63.65
Price range $54.93 - $74.36
New holding (+4.56 Thousand shares) Q1 2019
Avg closing price $57.14
Price range $39.87 - $69.36
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.